Literature DB >> 2788763

In vivo induction of interleukin-1 during hemodialysis.

N Haeffner-Cavaillon1, J M Cavaillon, C Ciancioni, F Bacle, S Delons, M D Kazatchkine.   

Abstract

In vivo induction of interleukin-1 (IL-1) production during hemodialysis was investigated by measuring IL-1 activity in monocyte lysates from 59 patients undergoing long-term maintenance hemodialysis with complement activating and non-complement activating devices. In patients dialyzed with new hollow-fiber cuprophane dialyzers, predialytic (T0) monocyte-associated IL-1 activity was 12.5 +/- 3.0 U/ml (mean +/- SEM), a value that was higher than that found in normal individuals (2.85 +/- 0.85 U/ml; P less than 0.0025) and in non-dialyzed patients with chronic renal failure (0.95 +/- 0.85 U/ml, P less than 0.0001). Cell-associated IL-1 activity was consistently increased after five hours of dialysis with cuprophane membranes (42.4 +/- 5.5 U/ml, P less than 0.0005). Systemic complement activation was demonstrated by the finding of increased plasma levels of C3adesArg antigen during dialysis. In patients dialyzed with high permeability polyacrylonitrile and polysulfone membranes, no intradialytic change in cell-associated IL-1 and no complement activation occurred. However, the mean predialytic values of monocyte-associated IL-1 in these patients (that is, 32.9 +/- 5.6 U/ml and 38 +/- 5.65 U/ml for the polyacrylonitrile and the polysulfone groups, respectively) were higher than the predialytic levels of cell-associated IL-1 in the patients from the cuprophane group (P less than 0.0025). Monocytes obtained at the beginning and five hours of dialysis from patients dialyzed with polyacrylonitrile devices, and monocytes obtained at five hours but not at the beginning of dialysis from patients dialyzed with cuprophane membranes, spontaneously released extracellular IL-1 after 24 hours of culture in serum free conditions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788763     DOI: 10.1038/ki.1989.112

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  In vitro complement activation after contact with pyrolytic carbon-coated and uncoated polyethylene terephthalate.

Authors:  E Cenni; D Granchi; G Ciapetti; S Stea; E Verri; S Gamberini; A Gori; A Pizzoferrato; P Zucchelli
Journal:  J Mater Sci Mater Med       Date:  1997-12       Impact factor: 3.896

2.  Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome.

Authors:  C Marie; C Fitting; C Cheval; M R Losser; J Carlet; D Payen; K Foster; J M Cavaillon
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Cytokine serum levels in patients with chronic HCV infection.

Authors:  Nick E Spanakis; George A Garinis; Evangelos C Alexopoulos; George P Patrinos; Panayotis G Menounos; Alexandra Sklavounou; Evangelos N Manolis; Vassilis G Gorgoulis; Dimitrios Valis
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

4.  Increased matrix metalloproteinases as possible cause of osseoarticular tissue destruction in long-term haemodialysis and beta 2-microglobulin amyloidosis.

Authors:  K Ohashi; R Kawai; M Hara; Y Okada; S Tachibana; Y Ogura
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

5.  Dysregulation of in vitro cytokine production by monocytes during sepsis.

Authors:  C Munoz; J Carlet; C Fitting; B Misset; J P Blériot; J M Cavaillon
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

6.  Leukocyte activation by isolated hyperthermic liver and limb perfusion due to malignancy.

Authors:  J P Arnestad; A Bengtsson; J P Bengtson; L Hafström; H Redl; G Schlag
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

7.  Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranes.

Authors:  A R Rosenkranz; E Templ; O Traindl; H Heinzl; G J Zlabinger
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

8.  Induction of tumour necrosis factor-alpha during haemodialysis. Influence of the membrane type.

Authors:  S Chollet-Martin; G Stamatakis; S Bailly; J P Mery; M A Gougerot-Pocidalo
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.